Cited 10 time in
Predictive role of optical coherence tomography angiography for exudation recurrence in patients with type 1 neovascular age-related macular degeneration treated with pro-re-nata protocol
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Mihyun | - |
| dc.contributor.author | Kim, Seong-Woo | - |
| dc.contributor.author | Yun, Cheolmin | - |
| dc.contributor.author | Oh, Jong-Hyun | - |
| dc.contributor.author | Oh, Jaeryung | - |
| dc.date.accessioned | 2023-04-27T08:40:23Z | - |
| dc.date.available | 2023-04-27T08:40:23Z | - |
| dc.date.issued | 2023-01 | - |
| dc.identifier.issn | 0950-222X | - |
| dc.identifier.issn | 1476-5454 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/2085 | - |
| dc.description.abstract | Objectives We sought to identify the consecutive changes and predictive features for exudation recurrence in macular neovascularization (MNV) using optical coherence tomography angiography (OCTA) in type 1 neovascular age-related macular degeneration (NVAMD). Methods A total of 291 OCTA images in consecutive visit of 45 patients newly diagnosed with type 1 NMV and treated with three loading intravitreal anti-vascular endothelial growth factor injections (IVIs) and a pro-re-nata (PRN) therapy regimen were analysed. Quantitative features of OCTA included the MNV area, MNV length, total number of endpoints (open-ended vessels) and junctions (internal branching) using AngioTool. Two subgroups were divided according to exudation recurrence time from the third IVI (group 1: <= 3 months vs. group 2: >3 months). Results The area, length, number of total junctions, and endpoints decreased during three loading IVIs and increased at exudation recurrence (all p < 0.05). In a subgroup analysis of consecutive OCTA images, the number of total endpoints increased at two months prior to exudate recurrence in group 2 (the late recurrence group, p = 0.020). A higher total number of endpoints of MNV at baseline were found to be related with group 1 (early recurrence, p = 0.020 and 0.012 in univariate and multivariate regression analyses). Conclusions The MNV with higher open-ended vessels at the lesion periphery at baseline might be expected to show earlier recurrence of exudation after loading IVIs. By observing the number of open-ended vessels in consecutive OCTA images, exudation recurrence could be predicted. | - |
| dc.format.extent | 8 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SPRINGER NATURE | - |
| dc.title | Predictive role of optical coherence tomography angiography for exudation recurrence in patients with type 1 neovascular age-related macular degeneration treated with pro-re-nata protocol | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1038/s41433-021-01879-2 | - |
| dc.identifier.scopusid | 2-s2.0-85122410984 | - |
| dc.identifier.wosid | 000739743600001 | - |
| dc.identifier.bibliographicCitation | Eye, v.37, no.1, pp 34 - 41 | - |
| dc.citation.title | Eye | - |
| dc.citation.volume | 37 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 34 | - |
| dc.citation.endPage | 41 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Ophthalmology | - |
| dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
| dc.subject.keywordPlus | CHOROIDAL NEOVASCULARIZATION | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordAuthor | Aflibercept | - |
| dc.subject.keywordAuthor | Vasculotropin A | - |
| dc.subject.keywordAuthor | Angiogenesis Inhibitors | - |
| dc.subject.keywordAuthor | Vascular Endothelial Growth Factor A | - |
| dc.subject.keywordAuthor | Eylea | - |
| dc.subject.keywordAuthor | Heyex | - |
| dc.subject.keywordAuthor | Spectralis | - |
| dc.subject.keywordAuthor | Aflibercept | - |
| dc.subject.keywordAuthor | Angiogenesis Inhibitor | - |
| dc.subject.keywordAuthor | Vasculotropin A | - |
| dc.subject.keywordAuthor | Adult | - |
| dc.subject.keywordAuthor | Aged | - |
| dc.subject.keywordAuthor | Article | - |
| dc.subject.keywordAuthor | Clinical Article | - |
| dc.subject.keywordAuthor | Cohort Analysis | - |
| dc.subject.keywordAuthor | Comparative Study | - |
| dc.subject.keywordAuthor | Controlled Study | - |
| dc.subject.keywordAuthor | Exudate | - |
| dc.subject.keywordAuthor | Female | - |
| dc.subject.keywordAuthor | Follow Up | - |
| dc.subject.keywordAuthor | Human | - |
| dc.subject.keywordAuthor | Male | - |
| dc.subject.keywordAuthor | Middle Aged | - |
| dc.subject.keywordAuthor | Optical Coherence Tomography Angiography | - |
| dc.subject.keywordAuthor | Predictive Value | - |
| dc.subject.keywordAuthor | Prospective Study | - |
| dc.subject.keywordAuthor | Recurrent Disease | - |
| dc.subject.keywordAuthor | Risk Factor | - |
| dc.subject.keywordAuthor | Wet Macular Degeneration | - |
| dc.subject.keywordAuthor | Fluorescence Angiography | - |
| dc.subject.keywordAuthor | Intravitreal Drug Administration | - |
| dc.subject.keywordAuthor | Macular Degeneration | - |
| dc.subject.keywordAuthor | Optical Coherence Tomography | - |
| dc.subject.keywordAuthor | Procedures | - |
| dc.subject.keywordAuthor | Retrospective Study | - |
| dc.subject.keywordAuthor | Subretinal Neovascularization | - |
| dc.subject.keywordAuthor | Angiogenesis Inhibitors | - |
| dc.subject.keywordAuthor | Choroidal Neovascularization | - |
| dc.subject.keywordAuthor | Fluorescein Angiography | - |
| dc.subject.keywordAuthor | Humans | - |
| dc.subject.keywordAuthor | Intravitreal Injections | - |
| dc.subject.keywordAuthor | Macular Degeneration | - |
| dc.subject.keywordAuthor | Retrospective Studies | - |
| dc.subject.keywordAuthor | Tomography, Optical Coherence | - |
| dc.subject.keywordAuthor | Vascular Endothelial Growth Factor A | - |
| dc.subject.keywordAuthor | Wet Macular Degeneration | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
